Mechanisms of self-nonself discrimination and possible clinical relevance

Immunotherapy

Volumn 1, Issue 4, 2009, Pages 631-644

  Daniel, Carolin ^a   Nolting, Jens ^a   Von Boehmer, Harald ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Conversion; Foxp3; Recessive and dominant tolerance; Regulatory T cell; Self nonself discrimination; Suppression; TGF

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; METHYLTRANSFERASE; RETINOIC ACID; TOLL LIKE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA;

ANTIGEN SPECIFICITY; CD8+ T LYMPHOCYTE; CELL EXPANSION; CELL MIGRATION; CELL SURVIVAL; DNA METHYLATION; EPIGENETICS; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANIMALS; AUTOANTIGENS; EPIGENESIS, GENETIC; HUMANS; IMMUNE TOLERANCE; LYMPHOCYTE ACTIVATION; LYMPHOPOIESIS; T-LYMPHOCYTES, REGULATORY; THYMUS GLAND; TRANSFORMING GROWTH FACTOR BETA;

EID: 77953374425     PISSN: 1750743X     EISSN: None     Source Type: Journal    
DOI: 10.2217/IMT.09.29     Document Type: Review

References (121)

1. Burnet FM: The Clonal Selection Theory. Cambridge Press, UK (1959).
2. Lederberg J: Genes and antibodies. Science 129(3364), 1649-1653 (1959).
3. Billingham RE, Brent L, Medawar PB: Actively acquired tolerance of foreign cells. Nature 172(4379), 603-606 (1953).
4. Kappler JW, Roehm N, Marrack P: T cell tolerance by clonal elimination in the thymus. Cell 49(2), 273-280 (1987).
5. + T cells: one population is deleted by ligation of αβ TCR. Cell 58(6), 1047-1054 (1989).
6. Martin S, Bevan MJ: Antigen-specific and nonspecific deletion of immature cortical thymocytes caused by antigen injection. Eur. J. Immunol. 27(10), 2726-2736 (1997).
7. Smith CA, Williams GT, Kingston R, Jenkinson EJ, Owen JJ: Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures. Nature 337(6203), 181-184 (1989). (Pubitemid 19025380)
8. + thymocytes. Nature 333(6175), 742-746 (1988). (Pubitemid 18172261)
9. Bruno L, Fehling HJ, von Boehmer H: The αβ T cell receptor can replace the γδ receptor in the development of γδ lineage cells. Immunity 5(4), 343-352 (1996). (Pubitemid 26366757)
10. Egawa T, Kreslavsky T, Littman DR, von Boehmer H: Lineage diversion of T cell receptor transgenic thymocytes revealed by lineage fate mapping. PLoS ONE 3(1), e1512 (2008). (Pubitemid 351827381)
11. von Boehmer H, Kirberg J, Rocha B: An unusual lineage of α/β T cells that contains autoreactive cells. J. Exp. Med. 174(5), 1001-1008 (1991).
12. + cells. Science 258(5082), 653-656 (1992).
13. + thymocytes in suspension culture by extrathymic antigen-presenting cells. Nature 351(6322), 150-153 (1991). (Pubitemid 21896554)
14. Buch T, Rieux-Laucat F, Forster I, Rajewsky K: Failure of HY-specific thymocytes to escape negative selection by receptor editing. Immunity 16(5), 707-718 (2002). •• Makes use of the HY-insertion model and points to negative selection of autoreactive thymocytes rather than receptor editing. (Pubitemid 34626691)
15. Bouillet P, Purton JF, Godfrey DI et al.: BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes. Nature 415(6874), 922-926 (2002). (Pubitemid 34174755)
16. Killeen N, Moriarty A, Teh HS, Littman DR: Requirement for CD8-major histocompatibility complex class I interaction in positive and negative selection of developing T cells. J. Exp. Med. 176(1), 89-97 (1992).
17. von Boehmer H, Kisielow P: Negative selection of the T-cell repertoire: where and when does it occur? Immunol. Rev. 209, 284-289 (2006).
18. Baldwin TA, Sandau MM, Jameson SC, Hogquist KA: The timing of TCR α expression critically influences T cell development and selection. J. Exp. Med. 202(1), 111-121 (2005).
19. McCaughtry TM, Baldwin TA, Wilken MS, Hogquist KA: Clonal deletion of thymocytes can occur in the cortex with no involvement of the medulla. J. Exp. Med. 205(11), 2575-2584 (2008).
20. + thymocytes. Eur. J. Immunol. 22(9), 2367-2372 (1992).
21. Sprent J, Kishimoto H: The thymus and negative selection. Immunol. Rev. 185, 126-135 (2002).
22. Nemazee D: Receptor editing in lymphocyte development and central tolerance. Nat. Rev. Immunol. 6(10), 728-740 (2006).
23. Nemazee D, Hogquist KA: Antigen receptor selection by editing or downregulation of V(D)J recombination. Curr. Opin. Immunol. 15(2), 182-189 (2003).
24. Rocha B, von Boehmer H: Peripheral selection of the T cell repertoire. Science 251(4998), 1225-1228 (1991).
25. Ramsdell F, Lantz T, Fowlkes BJ: A non-deletional mechanism of thymic self tolerance. Science 246(4933), 1038-1041 (1989). • Provided initial evidence that clonal anergy can also take place intrathymically. (Pubitemid 20010528)
26. + T cells. Int. Immunol. 4(5), 599-610 (1992).
27. Qin SX, Wise M, Cobbold SP et al.: Induction of tolerance in peripheral T cells with monoclonal antibodies. Eur. J. Immunol. 20(12), 2737-2745 (1990).
28. Rocha B, Tanchot C, von Boehmer H: Clonal anergy blocks in vivo growth of mature T cells and can be reversed in the absence of antigen. J. Exp. Med. 177(5), 1517-1521 (1993).
29. Bellgrau D, Gold D, Selawry H, Moore J, Franzusoff A, Duke RC: A role for CD95 ligand in preventing graft rejection. Nature 377(6550), 630-632 (1995).
30. Abbas AK: Die and let live: eliminating dangerous lymphocytes. Cell 84(5), 655-657 (1996).
31. Singer GG, Abbas AK: The fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1(5), 365-371 (1994).
32. + T cells after antigen challenge in the absence of Fas (CD95). Eur. J. Immunol. 26(12), 2903-2910 (1996).
33. Sarkar G, Sommer SS: Access to a messenger RNA sequence or its protein product is not limited by tissue or species specificity. Science 244(4902), 331-334 (1989). • First suggestion that the thymus might represent a patchwork quilt of diverse tissues at the RNA level. (Pubitemid 19117867)
34. Antonia SJ, Geiger T, Miller J, Flavell RA: Mechanisms of immune tolerance induction through the thymic expression of a peripheral tissue-specific protein. Int. Immunol. 7(5), 715-725 (1995).
35. Jolicoeur C, Hanahan D, Smith KM: T-cell tolerance toward a transgenic β-cell antigen and transcription of endogenous pancreatic genes in thymus. Proc. Natl Acad. Sci. USA 91(14), 6707-6711 (1994). •• Description of promiscous gene expression in the thymus.
36. Derbinski J, Schulte A, Kyewski B, Klein L: Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self. Nat. Immunol. 2(11), 1032-1039 (2001). • Data support the concept that medullary thymic epithelial cells (mTECs) express a wide range of tissue-specific antigens.
37. Ahonen P: Autoimmune polyendocrinopathy - candidosis - ectodermal dystrophy (APECED), autosomal recessive inheritance. Clin. Genet. 27(6), 535-542 (1985).
38. Anderson MS, Venanzi ES, Klein L et al.: Projection of an immunological self shadow within the thymus by the AIRE protein. Science 298(5597), 1395-1401 (2002). (Pubitemid 35346134)
39. Anderson MS, Venanzi ES, Chen Z et al.: The cellular mechanism of AIRE control of T cell tolerance. Immunity 23(2), 227-239 (2005). (Pubitemid 41169291)
40. Gray D, Abramson J, Benoist C, Mathis D: Proliferative arrest and rapid turnover of thymic epithelial cells expressing AIRE. J. Exp. Med. 204(11), 2521-2528 (2007).
41. Albert ML, Pearce SF, Francisco LM et al.: Immature dendritic cells phagocytose apoptotic cells via αvβ5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J. Exp. Med. 188(7), 1359-1368 (1998).
42. Albert ML, Sauter B, Bhardwaj N: Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 392(6671), 86-89 (1998). (Pubitemid 28150594)
43. Liston A, Lesage S, Wilson J, Peltonen L, Goodnow CC: AIRE regulates negative selection of organ-specific T cells. Nat. Immunol. 4(4), 350-354 (2003).
44. Derbinski J, Gabler J, Brors B et al.: Promiscuous gene expression in thymic epithelial cells is regulated at multiple levels. J. Exp. Med. 202(1), 33-45 (2005).
45. Koh AS, Kuo AJ, Park SY et al.: AIRE employs a histone-binding module to mediate immunological tolerance, linking chromatin regulation with organ-specific autoimmunity. Proc. Natl Acad. Sci. USA 105(41), 15878-15883 (2008).
46. + regulatory T cells induced by an agonist self-peptide. Nat. Immunol. 2(4), 301-306 (2001).
47. Apostolou I, Sarukhan A, Klein L, von Boehmer H: Origin of regulatory T cells with known specificity for antigen. Nat. Immunol. 3(8), 756-763 (2002). • Intrathymic expression of agonist ligands represents a powerful means for Treg generation.
48. + regulatory T cells in vivo. J. Exp. Med. 198(2), 249-258 (2003).
49. Klein L, Khazaie K, von Boehmer H: In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro. Proc. Natl Acad. Sci. USA 100(15), 8886-8891 (2003).
50. Fontenot JD, Rasmussen JP, Williams LM et al.: Regulatory T cell lineage specification by the forkhead transcription factor Foxp3. Immunity 22(3), 329-341 (2005).
51. + regulatory T cell biology. Curr. Top Microbiol. Immunol. 293, 25-42 (2005).
52. van Santen HM, Benoist C, Mathis D: Number of T reg cells that differentiate does not increase upon encounter of agonist ligand on thymic epithelial cells. J. Exp. Med. 200(10), 1221-1230 (2004).
53. Tai X, Cowan M, Feigenbaum L, Singer A: CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2. Nat. Immunol. 6(2), 152-162 (2005).
54. Holdorf AD, Green JM, Levin SD et al.: Proline residues in CD28 and the Src homology (SH)3 domain of Lck are required for T cell costimulation. J. Exp. Med. 190(3), 375-384 (1999).
55. Holdorf AD, Lee KH, Burack WR, Allen PM, Shaw AS: Regulation of Lck activity by CD4 and CD28 in the immunological synapse. Nat. Immunol. 3(3), 259-264 (2002).
56. + regulatory T cells in the absence of interleukin 2 signaling. Nat. Immunol. 6(11), 1152-1159 (2005).
57. Fontenot JD, Rasmussen JP, Gavin MA, Rudensky AY: A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat. Immunol. 6(11), 1142-1151 (2005).
58. + regulatory T cells. Nat. Immunol. 9(6), 632-640 (2008).
59. + medullary thymic epithelial cells. Nat. Immunol. 8(4), 351-358 (2007).
60. Jiang Q, Su H, Knudsen G, Helms W, Su L: Delayed functional maturation of natural regulatory T cells in the medulla of postnatal thymus: role of TSLP. BMC Immunol. 7, 6 (2006).
61. Gavin MA, Rasmussen JP, Fontenot JD et al.: Foxp3-dependent programme of regulatory T-cell differentiation. Nature 445 (7129), 771-775 (2007).
62. Lin W, Haribhai D, Relland LM et al.: Regulatory T cell development in the absence of functional Foxp3. Nat. Immunol. 8(4), 359-368 (2007).
63. Alvarez D, Vollmann EH, von Andrian UH: Mechanisms and consequences of dendritic cell migration. Immunity 29(3), 325-342 (2008).
64. Ashton-Rickardt PG, Bandeira A, Delaney JR et al.: Evidence for a differential avidity model of T cell selection in the thymus. Cell 76(4), 651-663 (1994). (Pubitemid 24070650)
65. Klein L, Klugmann M, Nave KA, Tuohy VK, Kyewski B: Shaping of the autoreactive T-cell repertoire by a splice variant of self protein expressed in thymic epithelial cells. Nat. Med. 6(1), 56-61 (2000).
66. Marson A, Kretschmer K, Frampton GM et al.: Foxp3 occupancy and regulation of key target genes during T-cell stimulation. Nature 445(7130), 931-935 (2007). (Pubitemid 46309829)
67. Chen C, Rowell EA, Thomas RM, Hancock WW, Wells AD: Transcriptional regulation by Foxp3 is associated with direct promoter occupancy and modulation of histone acetylation. J. Biol. Chem. 281(48), 36828-36834 (2006).
68. + regulatory T cell function. Science 322(5899), 271-275 (2008).
69. Paust S, Lu L, McCarty N, Cantor H: Engagement of B7 on effector T cells by regulatory T cells prevents autoimmune disease. Proc. Natl Acad. Sci. USA 101(28), 10398-10403 (2004).
70. Apostolou I, Sarukhan A, Klein L, von Boehmer H: Origin of regulatory T cells with known specificity for antigen. Nat. Immunol. 3(8), 756-763 (2002).
71. Hao Y, Legrand N, Freitas AA: The clone size of peripheral CD8 T cells is regulated by TCR promiscuity. J. Exp. Med. 203(7), 1643-1649 (2006).
72. Kretschmer K, Apostolou I, Hawiger D, Khazaie K, Nussenzweig MC, von Boehmer H: Inducing and expanding regulatory T cell populations by foreign antigen. Nat. Immunol. 6(12), 1219-1227 (2005). • Establishment of these protocols added a new dimension to our understanding of antigen-specific tolerance mechanisms.
73. Apostolou I, von Boehmer H: In vivo instruction of suppressor commitment in naive T cells. J. Exp. Med. 199(10), 1401-1408 (2004). • Establishment of these protocols added a new dimension to our understanding of antigen-specific tolerance mechanisms.
74. Kretschmer K, Heng TS, von Boehmer H: De novo production of antigen-specific suppressor cells in vivo. Nat. Protoc. 1(2), 653-661 (2006).
75. Verginis P, McLaughlin KA, Wucherpfennig KW, von Boehmer H, Apostolou I: Induction of antigen-specific regulatory T cells in wild-type mice: visualization and targets of suppression. Proc. Natl Acad. Sci. USA 105(9), 3479-3484 (2008).
76. + regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J. Exp. Med. 201(5), 723-735 (2005).
77. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188(2), 287-296 (1998).
78. +. J. Exp. Med. 198(12), 1875-1886 (2003).
79. + T-cell pool and the expression of Foxp3 in vivo. Int. Immunol. 16(9), 1241-1249 (2004).
80. Mempel TR, Pittet MJ, Khazaie K et al.: Regulatory T cells reversibly suppress cytotoxic T cell function independent of effector differentiation. Immunity 25(1), 129-141 (2006). (Pubitemid 44066829)
81. + T lymphocytes. Inhibition by transforming growth factor-β. J. Immunol. 146(10), 3289-3297 (1991).
82. Deaglio S, Dwyer KM, Gao W et al.: Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J. Exp. Med. 204(6), 1257-1265 (2007).
83. Li MO, Sanjabi S, Flavell RA: Transforming growth factor-β controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. Immunity 25(3), 455-471 (2006). (Pubitemid 44354214)
84. + regulatory T cells. J. Exp. Med. 201(7), 1061-1067 (2005).
85. + regulatory T cells responsible for protection against diabetes. Proc. Natl Acad. Sci. USA 101(13), 4572-4577 (2004).
86. Bruder D, Westendorf AM, Hansen W et al.: On the edge of autoimmunity: T-cell stimulation by steady-state dendritic cells prevents autoimmune diabetes. Diabetes 54(12), 3395-3401 (2005). (Pubitemid 43334328)
87. + regulatory T cells. J. Exp. Med. 201(5), 737-746 (2005).
88. + regulatory T cell-mediated immunosuppression. Cytokine Growth Factor Rev. 14(2), 85-89 (2003). (Pubitemid 36389522)
89. + regulatory T cells via a TGF-β and retinoic acid-dependent mechanism. J. Exp. Med. 204(8), 1757-1764 (2007).
90. Mucida D, Park Y, Kim G et al.: Reciprocal Th17 and regulatory T cell differentiation mediated by retinoic acid. Science 317(5835), 256-260 (2007). (Pubitemid 47076203)
91. Sun CM, Hall JA, Blank RB et al.: Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J. Exp. Med. 204(8), 1775-1785 (2007).
92. Benson MJ, Pino-Lagos K, Rosemblatt M, Noelle RJ: All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation. J. Exp. Med. 204(8), 1765-1774 (2007).
93. hi cells. Immunity 29(5), 758-770 (2008).
94. + regulatory T cells and inhibits development of Th17 cells by enhancing TGF-β-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression. J. Immunol. 181(4), 2277-2284 (2008).
95. Denison MS, Nagy SR: Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu. Rev. Pharmacol. Toxicol. 43, 309-334 (2003).
96. Quintana FJ, Basso AS, Iglesias AH et al.: Control of T(reg) and Th17 cell differentiation by the aryl hydrocarbon receptor. Nature 453(7191), 65-71 (2008).
97. Veldhoen M, Hirota K, Westendorf AM et al.: The aryl hydrocarbon receptor links Th17-cell-mediated autoimmunity to environmental toxins. Nature 453(7191), 106-109 (2008). (Pubitemid 351630329)
98. Jaenisch R, Bird A: Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat. Genet. 33, 245-254 (2003).
99. Riggs AD: X inactivation, differentiation, and DNA methylation. Cytogenet. Cell Genet. 14(1), 9-25 (1975).
100. Holliday R, Pugh JE: DNA modification mechanisms and gene activity during development. Science 187(4173), 226-232 (1975).
101. Bestor TH: The DNA methyltransferases of mammals. Hum. Mol. Genet. 9(16), 2395-2402 (2000).
102. +) conventional T cells. Eur. J. Immunol. 37(9), 2378-2389 (2007).
103. Polansky JK, Kretschmer K, Freyer J et al.: DNA methylation controls Foxp3 gene expression. Eur. J. Immunol. 38(6), 1654-1663 (2008).
104. Floess S, Freyer J, Siewert C et al.: Epigenetic control of the Foxp3 locus in regulatory T cells. PLoS Biol. 5(2), e38 (2007). (Pubitemid 46256667)
105. Kim HP, Leonard WJ: CREB/ATF-dependent T cell receptor-induced FoxP3 gene expression: a role for DNA methylation. J. Exp. Med. 204(7), 1543-1551 (2007).
106. + regulatory T cells in transplantation: progress, challenges and prospects. Am. J. Transplant. 7(6), 1457-1463 (2007).
107. Bendelac A, Bonneville M, Kearney JF: Autoreactivity by design: innate B and T lymphocytes. Nat. Rev. Immunol. 1(3), 177-186 (2001).
108. Bendelac A, Savage PB, Teyton L: The biology of NKT cells. Annu. Rev. Immunol. 25, 297-336 (2007).
109. Kronenberg M, Gapin L: The unconventional lifestyle of NKT cells. Nat. Rev. Immunol. 2(8), 557-568 (2002).
110. Wilson SB, Kent SC, Patron KT et al.: Extreme Th1 bias of invariant Va24JαQT cells in Type 1 diabetes. Nature 391 (6663), 177-181 (1998).
111. Wilson SB, Delovitch TL: Janus-like role of regulatory iNKT cells in autoimmune disease and tumour immunity. Nat. Rev. Immunol. 3(3), 211-222 (2003).
112. Halder RC, Aguilera C, Maricic I, Kumar V: Type II NKT cell-mediated anergy induction in type I NKT cells prevents inflammatory liver disease. J. Clin. Invest. 117(8), 2302-2312 (2007).
113. Gershon RK, Kondo K: Cell interactions in the induction of tolerance: the role of thymic lymphocytes. Immunology 18(5), 723-737 (1970).
114. + T cells expressing V β 8 TCR: a role of the Qa-1 molecule. Immunity 2(2), 185-194 (1995).
115. Vance RE, Kraft JR, Altman JD, Jensen PE, Raulet DH: Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b). J. Exp. Med. 188(10), 1841-1848 (1998).
116. + T cell responses. Nat. Immunol. 3(2), 189-195 (2002).
117. + T cells by NK cells via the Qa-1-NKG2A inhibitory pathway. Immunity 26(5), 593-604 (2007).
118. Myers L, Croft M, Kwon BS, Mittler RS, Vella AT: Peptide-specific CD8 T regulatory cells use IFN-γ to elaborate TGF-β-based suppression. J. Immunol. 174(12), 7625-7632 (2005). (Pubitemid 40806267)
119. Seo SK, Choi JH, Kim YH et al.: 4-1BB-mediated immunotherapy of rheumatoid arthritis. Nat. Med. 10(10), 1088-1094 (2004).
120. + regulatory T cells. Cell Mol. Immunol. 5(6), 401-406 (2008).
121. + Treg-mediated suppression. Trends Immunol. 29(7), 337-342 (2008).